379 related articles for article (PubMed ID: 6970515)
21. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
Devi BS; Van Noordin S; Krausz T; Davies KA
J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
[TBL] [Abstract][Full Text] [Related]
22. Levamisole and human lymphocyte surface markers.
Wybran J; Govaerts A
Clin Exp Immunol; 1977 Feb; 27(2):319-21. PubMed ID: 321166
[TBL] [Abstract][Full Text] [Related]
23. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
24. Increased double marker lymphocytes in systemic lupus erythematosus and lymphoproliferative disorders.
Niwa Y; Ou DW; Waterhouse JP; Yokoyama MM; Miyake S
J Clin Lab Immunol; 1982 Feb; 7(2):105-10. PubMed ID: 6978406
[TBL] [Abstract][Full Text] [Related]
25. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
26. Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
Robak E; Błoński JZ; Bartkowiak J; Niewiadomska H; Sysa-Jedrzejowska A; Robak T
Mediators Inflamm; 1999; 8(6):305-12. PubMed ID: 10815619
[TBL] [Abstract][Full Text] [Related]
27. [Effect of levamisole on cellular immunity indices in chronic bronchitis and chronic pneumonia patients].
Borisova AM; Novikova TA; Glazko AV
Ter Arkh; 1984; 56(10):29-31. PubMed ID: 6335306
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid.
Joffe MI; Sukha NR; Rabson AR
J Clin Invest; 1983 Sep; 72(3):971-80. PubMed ID: 6604071
[TBL] [Abstract][Full Text] [Related]
29. Treatment of systemic lupus erythematosus with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum period of four months.
Gordon BL; Yanagihara R
Ann Allergy; 1977 Oct; 39(4):227-36. PubMed ID: 71868
[TBL] [Abstract][Full Text] [Related]
30. Phagocyte function and cell-mediated immunity in systemic lupus erythematosus.
Landry M
Arch Dermatol; 1977 Feb; 113(2):147-54. PubMed ID: 300001
[TBL] [Abstract][Full Text] [Related]
31. Lymphocyte subsets in systemic lupus erythematosus.
Cheong SK; Chin SF; Kong NC
Malays J Pathol; 1997 Dec; 19(2):121-5. PubMed ID: 10879252
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
33. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
34. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
35. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
Sansoni P; Rossetti A; Valente G; Butturini U
Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
[No Abstract] [Full Text] [Related]
36. Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus.
Utsinger PD
J Rheumatol; 1976 Jun; 3(2):175-85. PubMed ID: 1084929
[TBL] [Abstract][Full Text] [Related]
37. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
38. Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.
Zulman J; Michalski J; McCombs C; Greenspan J; Talal N
Clin Exp Immunol; 1978 Feb; 31(2):321-7. PubMed ID: 306328
[TBL] [Abstract][Full Text] [Related]
39. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
[TBL] [Abstract][Full Text] [Related]
40. Decreased recent thymus emigrant number is associated with disease activity in systemic lupus erythematosus.
Vieira QF; Kayser C; Kallas EG; Andrade LE
J Rheumatol; 2008 Sep; 35(9):1762-7. PubMed ID: 18634155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
